Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Epidemiol Infect

Retrieve available abstracts of 311 articles:
HTML format

Single Articles

    September 2021
  1. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.

  2. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    PubMed     Abstract available

    August 2021
  3. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    PubMed     Abstract available

  4. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    PubMed     Abstract available

  5. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    PubMed     Abstract available

  6. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    PubMed     Abstract available

  7. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    PubMed     Abstract available

  8. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    PubMed     Abstract available

    July 2021
  9. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    PubMed     Abstract available

  10. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    PubMed     Abstract available

  11. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    PubMed     Abstract available

  12. THOMAS BS, Marks NA
    Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
    Epidemiol Infect. 2021;149:e197.
    PubMed     Abstract available

  13. BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
    Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
    Epidemiol Infect. 2021;149:e161.
    PubMed     Abstract available

    Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
    Epidemiol Infect. 2021;149:e156.
    PubMed     Abstract available

  15. DITE GS, Murphy NM, Allman R
    Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
    Epidemiol Infect. 2021;149:e162.
    PubMed     Abstract available

  16. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    PubMed     Abstract available

    June 2021
    RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
    Epidemiol Infect. 2021;149:e151.

  18. GEORGE CE, Inbaraj LR
    Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e152.

  19. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    PubMed     Abstract available

  20. WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
    Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e150.
    PubMed     Abstract available

  21. ZHANG R, Gao Y, Xie D, Lian R, et al
    Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
    Epidemiol Infect. 2021;149:e146.
    PubMed     Abstract available

  22. MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
    COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
    Epidemiol Infect. 2021;149:e145.
    PubMed     Abstract available

  23. DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
    Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    Epidemiol Infect. 2021;149:e140.
    PubMed     Abstract available

  24. GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
    Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Epidemiol Infect. 2021;149:e137.
    PubMed     Abstract available

    May 2021
  25. JAIN J, Saurabh S, Kumar P, Verma MK, et al
    COVID-19 vaccine hesitancy among medical students in India.
    Epidemiol Infect. 2021;149:e132.
    PubMed     Abstract available

  26. MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
    Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
    Epidemiol Infect. 2021;149:e129.
    PubMed     Abstract available

  27. DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
    Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    Epidemiol Infect. 2021;149:e130.
    PubMed     Abstract available

  28. HAMMER CC, Cristea V, Dub T, Sivela J, et al
    High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Epidemiol Infect. 2021;149:e123.
    PubMed     Abstract available

    April 2021
  29. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    PubMed     Abstract available

  30. CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
    Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
    Epidemiol Infect. 2021;149:e118.
    PubMed     Abstract available

  31. ZHAO S, Yang Z, Musa SS, Ran J, et al
    Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
    Epidemiol Infect. 2021;149:e107.
    PubMed     Abstract available

  32. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    PubMed     Abstract available

  33. MOUSSA R, Majdalani S
    Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
    Epidemiol Infect. 2021;149:e138.
    PubMed     Abstract available

  34. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    PubMed     Abstract available

  35. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    PubMed     Abstract available

  36. LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
    Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
    Epidemiol Infect. 2021;149:e102.
    PubMed     Abstract available

  37. KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
    Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Epidemiol Infect. 2021;149:e139.
    PubMed     Abstract available

  38. ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
    Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Epidemiol Infect. 2021;149:e157.
    PubMed     Abstract available

  39. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    PubMed     Abstract available

  40. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    PubMed     Abstract available

  41. LUO S, Xin M, Wang S, Zhao J, et al
    Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
    Epidemiol Infect. 2021;149:e158.
    PubMed     Abstract available

  42. ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
    COVID-19 re-infection in Shahroud, Iran: a follow-up study.
    Epidemiol Infect. 2021;149:e159.
    PubMed     Abstract available

  43. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    PubMed     Abstract available

  44. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    PubMed     Abstract available

  45. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    PubMed     Abstract available

  46. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    PubMed     Abstract available

  47. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    PubMed     Abstract available

  48. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    PubMed     Abstract available

    March 2021
  49. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    PubMed     Abstract available

  50. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    PubMed     Abstract available

  51. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    PubMed     Abstract available

  52. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    PubMed     Abstract available

  53. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    PubMed     Abstract available

  54. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    PubMed     Abstract available

  55. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    PubMed     Abstract available

  56. ELSON R, Davies TM, Lake IR, Vivancos R, et al
    The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
    Epidemiol Infect. 2021;149:e73.
    PubMed     Abstract available

    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    PubMed     Abstract available

  58. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    PubMed     Abstract available

    February 2021
  59. CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
    Spatial dynamics of the COVID-19 pandemic in Brazil.
    Epidemiol Infect. 2021;149:e60.
    PubMed     Abstract available

  60. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    PubMed     Abstract available

  61. CHENG A, Chen Y, Gao Y, Sun P, et al
    Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e61.
    PubMed     Abstract available

  62. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    PubMed     Abstract available

  63. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    PubMed     Abstract available

  64. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    PubMed     Abstract available

  65. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    PubMed     Abstract available

  66. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    PubMed     Abstract available

  67. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    PubMed     Abstract available

  68. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    PubMed     Abstract available

  69. AI J, Shi N, Shi Y, Xu K, et al
    Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
    Epidemiol Infect. 2021;149:e48.
    PubMed     Abstract available

  70. SHANG C, Yang Y, Chen GY, Shang XD, et al
    A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
    Epidemiol Infect. 2021;149:e43.
    PubMed     Abstract available

  71. BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
    Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
    Epidemiol Infect. 2021;149:e44.
    PubMed     Abstract available

  72. WEIBELZAHL S, Reiter J, Duden G
    Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e46.
    PubMed     Abstract available

  73. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    PubMed     Abstract available

  74. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    PubMed     Abstract available

  75. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    PubMed     Abstract available

    January 2021
  76. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    PubMed     Abstract available

  77. PRANATA R, Lim MA, Yonas E, Huang I, et al
    Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
    Epidemiol Infect. 2021;149:e40.
    PubMed     Abstract available

    Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e35.

  79. CHOW WK, Chow CL
    Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e33.

  80. WANG Y, Luo H, Liu S, Hao T, et al
    Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
    Epidemiol Infect. 2021;149:e31.
    PubMed     Abstract available

  81. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    PubMed     Abstract available

  82. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    PubMed     Abstract available

  83. WENG CH, Saal A, McGuire DC, Chan PA, et al
    Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
    Epidemiol Infect. 2021;149:e25.
    PubMed     Abstract available

  84. LE TD, Bosworth M, Ledlow G, Le TT, et al
    Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
    Epidemiol Infect. 2021;149:e28.
    PubMed     Abstract available

  85. WEI J, Guo S, Long E, Zhang L, et al
    Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
    Epidemiol Infect. 2021;149:e24.
    PubMed     Abstract available

  86. ISHIKAWA G, Argenti G, Fadel CB
    Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
    Epidemiol Infect. 2021;149:e23.
    PubMed     Abstract available

  87. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    PubMed     Abstract available

  88. GE Y, Sun S, Shen Y
    Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
    Epidemiol Infect. 2021;149:e14.
    PubMed     Abstract available

  89. SALMON RL, Monaghan SP
    Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
    Epidemiol Infect. 2021;149:e13.
    PubMed     Abstract available

  90. SHARIF N, Dey SK
    Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
    Epidemiol Infect. 2021;149:e16.
    PubMed     Abstract available

  91. LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
    Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
    Epidemiol Infect. 2021;149:e19.
    PubMed     Abstract available

  92. ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
    Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
    Epidemiol Infect. 2021;149:e15.
    PubMed     Abstract available

  93. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    PubMed     Abstract available

  94. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    PubMed     Abstract available

  95. CHOW WK, Chow CL
    A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
    Epidemiol Infect. 2021;149:e17.
    PubMed     Abstract available

  96. DENG L, Zhang J, Wang M, Chen L, et al
    Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
    Epidemiol Infect. 2021;149:e144.
    PubMed     Abstract available

    December 2020
  97. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    PubMed     Abstract available

  98. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    PubMed     Abstract available

  99. YANG J, Ma Z, Lei Y
    A meta-analysis of the association between obesity and COVID-19.
    Epidemiol Infect. 2020;149:e11.
    PubMed     Abstract available

  100. ARINO J, Bajeux N, Portet S, Watmough J, et al
    Quarantine and the risk of COVID-19 importation.
    Epidemiol Infect. 2020;148:e298.
    PubMed     Abstract available

  101. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    PubMed     Abstract available

  102. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.

  103. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    PubMed     Abstract available

  104. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    PubMed     Abstract available

  105. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    PubMed     Abstract available

    November 2020
  106. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    PubMed     Abstract available

  107. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    PubMed     Abstract available

  108. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    PubMed     Abstract available

  109. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    PubMed     Abstract available

  110. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    PubMed     Abstract available

  111. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    PubMed     Abstract available

  112. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    PubMed     Abstract available

  113. SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
    Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Epidemiol Infect. 2020;148:e300.
    PubMed     Abstract available

  114. KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
    The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
    Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.

  115. GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
    Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
    Epidemiol Infect. 2020;148:e270.
    PubMed     Abstract available

  116. GURSAKAL N, Batmaz B, Aktuna G
    Drawing transmission graphs for COVID-19 in the perspective of network science.
    Epidemiol Infect. 2020;148:e269.
    PubMed     Abstract available

    October 2020
  117. ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
    Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Epidemiol Infect. 2020;148:e263.
    PubMed     Abstract available

  118. RIVERA R, Rosenbaum JE, Quispe W
    Excess mortality in the United States during the first three months of the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e264.
    PubMed     Abstract available

  119. MAJUMDAR P, Niyogi S
    ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Epidemiol Infect. 2020;148:e262.
    PubMed     Abstract available

  120. MEIKSIN A
    Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
    Epidemiol Infect. 2020;148:e257.
    PubMed     Abstract available

  121. ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
    Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
    Epidemiol Infect. 2020;148:e261.
    PubMed     Abstract available

  122. ZENG L, Wang S, Cai J, Sun S, et al
    Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e266.
    PubMed     Abstract available

  123. DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
    Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
    Epidemiol Infect. 2020;148:e268.
    PubMed     Abstract available

  124. LI X, Marmar T, Xu Q, Tu J, et al
    Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
    Epidemiol Infect. 2020;148:e255.
    PubMed     Abstract available

  125. BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
    Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
    Epidemiol Infect. 2020;148:e252.
    PubMed     Abstract available

  126. TEIXEIRA R, Doetsch J
    The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e244.
    PubMed     Abstract available

  127. TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
    Epidemiol Infect. 2020;148:e250.
    PubMed     Abstract available

  128. GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
    Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e251.
    PubMed     Abstract available

  129. KHAN ZS, Van Bussel F, Hussain F
    A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
    Epidemiol Infect. 2020;148:e249.
    PubMed     Abstract available

  130. SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
    SARS-CoV-2 transmission: a sociological review.
    Epidemiol Infect. 2020;148:e242.
    PubMed     Abstract available

  131. WANG Y, Xu C, Yao S, Zhao Y, et al
    Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
    Epidemiol Infect. 2020;148:e236.
    PubMed     Abstract available

  132. GUO J, Zhou B, Zhu M, Yuan Y, et al
    CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e241.
    PubMed     Abstract available

    September 2020
  133. SHI P, Ren G, Yang J, Li Z, et al
    Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
    Epidemiol Infect. 2020;148:e238.
    PubMed     Abstract available

  134. SINGH D, Joshi K, Samuel A, Patra J, et al
    Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
    Epidemiol Infect. 2020;148:e229.
    PubMed     Abstract available

  135. LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
    Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    Epidemiol Infect. 2020;148:e233.
    PubMed     Abstract available

  136. FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
    Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
    Epidemiol Infect. 2020;148:e231.
    PubMed     Abstract available

  137. GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
    The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
    Epidemiol Infect. 2020;148:e226.
    PubMed     Abstract available

  138. SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
    Social network analysis of COVID-19 transmission in Karnataka, India.
    Epidemiol Infect. 2020;148:e230.
    PubMed     Abstract available

  139. ZONGO P, Zorom M, Mophou G, Dorville R, et al
    A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
    Epidemiol Infect. 2020;148:e221.
    PubMed     Abstract available

  140. CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
    The COVID-19 pandemic: the public health reality.
    Epidemiol Infect. 2020;148:e223.
    PubMed     Abstract available

  141. CHEN M, Wei X, Wang Z
    Protecting healthcare workers from SARS-CoV-2 and other infections.
    Epidemiol Infect. 2020;148:e217.
    PubMed     Abstract available

  142. AHMAD I, Muhammad Asad S
    Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
    Epidemiol Infect. 2020;148:e222.
    PubMed     Abstract available

  143. CHEN LZ, Lin ZH, Chen J, Liu SS, et al
    Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
    Epidemiol Infect. 2020;148:e218.
    PubMed     Abstract available

  144. SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
    Public attitude towards quarantine during the COVID-19 outbreak.
    Epidemiol Infect. 2020;148:e220.
    PubMed     Abstract available

  145. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    PubMed     Abstract available

  146. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    PubMed     Abstract available

  147. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    PubMed     Abstract available

  148. PETTI S, Cowling BJ
    Ecologic association between influenza and COVID-19 mortality rates in European countries.
    Epidemiol Infect. 2020 Sep 11:1-21. doi: 10.1017/S0950268820002125.

  149. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    PubMed     Abstract available

  150. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    PubMed     Abstract available

  151. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    PubMed     Abstract available

  152. SANTOS MM, Lucena EES, Lima KC, Brito AAC, et al
    Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil.
    Epidemiol Infect. 2020;148:e198.
    PubMed     Abstract available

    D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.
    Epidemiol Infect. 2020;148:e202.
    PubMed     Abstract available

  154. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    PubMed     Abstract available

  155. ZHANG L, Huang B, Xia H, Fan H, et al
    Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases.
    Epidemiol Infect. 2020;148:e199.
    PubMed     Abstract available

  156. ZHAO W, Xie X, Liu J
    The importance of distinguishing COVID-19 from more common respiratory illnesses.
    Epidemiol Infect. 2020;148:e195.
    PubMed     Abstract available

  157. CHEN X, Gao H, Zou Y, Lin F, et al
    Changes in psychological wellbeing, attitude and information-seeking behaviour among people at the epicentre of the COVID-19 pandemic: a panel survey of residents in Hubei province, China.
    Epidemiol Infect. 2020;148:e201.
    PubMed     Abstract available

  158. TAN WYT, Wong LY, Leo YS, Toh MPHS, et al
    Does incubation period of COVID-19 vary with age? A study of epidemiologically linked cases in Singapore.
    Epidemiol Infect. 2020;148:e197.
    PubMed     Abstract available

  159. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    PubMed     Abstract available

    August 2020
  160. MAMISHI S, Movahedi Z, Mohammadi M, Ziaee V, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
    Epidemiol Infect. 2020;148:e196.
    PubMed     Abstract available

  161. TEMSAH MH, Alhuzaimi AN, Alamro N, Alrabiaah A, et al
    Knowledge, attitudes and practices of healthcare workers during the early COVID-19 pandemic in a main, academic tertiary care centre in Saudi Arabia.
    Epidemiol Infect. 2020;148:e203.
    PubMed     Abstract available

  162. CHANU AL, Singh RKB
    Stochastic approach to study control strategies of Covid-19 pandemic in India.
    Epidemiol Infect. 2020;148:e200.
    PubMed     Abstract available

  163. HOLDEN B, Quinney A, Padfield S, Morton W, et al
    COVID-19: public health management of the first two confirmed cases identified in the UK.
    Epidemiol Infect. 2020;148:e194.
    PubMed     Abstract available

  164. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five unusual presentations in patients with COVID-19: results of the UMC-19-S1.
    Epidemiol Infect. 2020;148:e189.
    PubMed     Abstract available

  165. KHRAIBANI Z, Khraibani J, Kobeissi M, Atoui A, et al
    Application of records theory on the COVID-19 pandemic in Lebanon: prediction and prevention.
    Epidemiol Infect. 2020;148:e192.
    PubMed     Abstract available

  166. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    PubMed     Abstract available

  167. DARCIS G, Vaira D, Moutschen M
    Impact of coronavirus pandemic and containment measures on HIV diagnosis.
    Epidemiol Infect. 2020;148:e185.
    PubMed     Abstract available

  168. GOMES DS, Andrade LA, Ribeiro CJN, Peixoto MVS, et al
    Risk clusters of COVID-19 transmission in northeastern Brazil: prospective space-time modelling.
    Epidemiol Infect. 2020;148:e188.
    PubMed     Abstract available

  169. ROUEN A, Adda J, Roy O, Rogers E, et al
    COVID-19: relationship between atmospheric temperature and daily new cases growth rate.
    Epidemiol Infect. 2020;148:e184.
    PubMed     Abstract available

  170. GROTTO RMT, Santos Lima R, de Almeida GB, Ferreira CP, et al
    Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil.
    Epidemiol Infect. 2020;148:e178.
    PubMed     Abstract available

  171. LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
    Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Epidemiol Infect. 2020;148:e170.
    PubMed     Abstract available

  172. OU M, Zhu J, Ji P, Li H, et al
    Risk factors of severe cases with COVID-19: a meta-analysis.
    Epidemiol Infect. 2020;148:e175.
    PubMed     Abstract available

  173. CHANDA A
    COVID-19 in India: transmission dynamics, epidemiological characteristics, testing, recovery and effect of weather.
    Epidemiol Infect. 2020;148:e182.
    PubMed     Abstract available

  174. JIANG H, Liu JW, Ren N, He R, et al
    Emergency management in fever clinic during the outbreak of COVID-19: an experience from Zhuhai.
    Epidemiol Infect. 2020;148:e174.
    PubMed     Abstract available

  175. LING C, Wen X
    Community grid management is an important measure to contain the spread of novel coronavirus pneumonia (COVID-19).
    Epidemiol Infect. 2020;148:e167.
    PubMed     Abstract available

  176. PIKOVSKI A, Bentele K
    Pooling of coronavirus tests under unknown prevalence.
    Epidemiol Infect. 2020;148:e183.
    PubMed     Abstract available

  177. ADEKUNLE AI, Adegboye OA, Gayawan E, McBryde ES, et al
    Is Nigeria really on top of COVID-19? Message from effective reproduction number.
    Epidemiol Infect. 2020;148:e166.
    PubMed     Abstract available

  178. MA X, Ng M, Xu S, Xu Z, et al
    Development and validation of prognosis model of mortality risk in patients with COVID-19.
    Epidemiol Infect. 2020;148:e168.
    PubMed     Abstract available

  179. YANG H, Chen D, Jiang Q, Yuan Z, et al
    High intensities of population movement were associated with high incidence of COVID-19 during the pandemic.
    Epidemiol Infect. 2020;148:e177.
    PubMed     Abstract available

    July 2020
  180. MAZUMDER A, Arora M, Sra MS, Gupta A, et al
    Geographical variation in case fatality rate and doubling time during the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e163.
    PubMed     Abstract available

  181. LI L, Chen C
    Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
    Epidemiol Infect. 2020;148:e164.
    PubMed     Abstract available

  182. ZHANG X, Wang Y
    Prevention and control mechanism for coronavirus disease 2019 epidemic at the primary level: perspective from China.
    Epidemiol Infect. 2020;148:e161.
    PubMed     Abstract available

  183. YANG HM, Lombardi Junior LP, Castro FFM, Yang AC, et al
    Mathematical model describing CoViD-19 in Sao Paulo, Brazil - evaluating isolation as control mechanism and forecasting epidemiological scenarios of release.
    Epidemiol Infect. 2020;148:e155.
    PubMed     Abstract available

  184. LI YH, Fan YZ, Jiang L, Wang HB, et al
    Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients.
    Epidemiol Infect. 2020;148:e154.
    PubMed     Abstract available

  185. WENG CH, Saal A, Butt WW, Bica N, et al
    Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study.
    Epidemiol Infect. 2020;148:e140.
    PubMed     Abstract available

  186. KONG M, Zhang H, Cao X, Mao X, et al
    Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
    Epidemiol Infect. 2020;148:e139.
    PubMed     Abstract available

  187. SUN Y, Tian L, Du X, Wang H, et al
    Epidemiological and clinical characteristics of a familial cluster of COVID-19.
    Epidemiol Infect. 2020;148:e145.
    PubMed     Abstract available

  188. XU K, Zhou M, Yang D, Ling Y, et al
    Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.
    Epidemiol Infect. 2020;148:e146.
    PubMed     Abstract available

  189. QI C, Zhu YC, Li CY, Hu YC, et al
    Epidemiological characteristics and spatial-temporal analysis of COVID-19 in Shandong Province, China.
    Epidemiol Infect. 2020;148:e141.
    PubMed     Abstract available

  190. LI J, Ding J, Chen L, Hong L, et al
    Epidemiological and clinical characteristics of three family clusters of COVID-19 transmitted by latent patients in China.
    Epidemiol Infect. 2020;148:e137.
    PubMed     Abstract available

  191. FENG X, Ding X, Zhang F
    Dynamic evolution of lung abnormalities evaluated by quantitative CT techniques in patients with COVID-19 infection.
    Epidemiol Infect. 2020;148:e136.
    PubMed     Abstract available

  192. QIN W, Sun J, Xu P, Gong T, et al
    The descriptive epidemiology of coronavirus disease 2019 during the epidemic period in Lu'an, China: achieving limited community transmission using proactive response strategies.
    Epidemiol Infect. 2020;148:e132.
    PubMed     Abstract available

    June 2020
  193. LIU Q, Song NC, Zheng ZK, Li JS, et al
    Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.
    Epidemiol Infect. 2020;148:e129.
    PubMed     Abstract available

  194. LU B, Wang YC, Zhu ZS, Zhang Z, et al
    Epidemiological and genetic characteristics of influenza virus and the effects of air pollution on laboratory-confirmed influenza cases in Hulunbuir, China, from 2010 to 2019.
    Epidemiol Infect. 2020 Jun 29:1-32. doi: 10.1017/S0950268820001387.

  195. KHALILI M, Karamouzian M, Nasiri N, Javadi S, et al
    Epidemiological characteristics of COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e130.
    PubMed     Abstract available

  196. SOUSA GJB, Garces TS, Cestari VRF, Florencio RS, et al
    Mortality and survival of COVID-19.
    Epidemiol Infect. 2020;148:e123.
    PubMed     Abstract available

  197. HAN J, Shi LX, Xie Y, Zhang YJ, et al
    Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration.
    Epidemiol Infect. 2020;148:e125.
    PubMed     Abstract available

  198. ENZMANN MO, Erickson MP, Grindeland CJ, Lopez SMC, et al
    Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas.
    Epidemiol Infect. 2020;148:e124.
    PubMed     Abstract available

  199. BRLEK A, Vidovic S, Vuzem S, Turk K, et al
    Possible indirect transmission of COVID-19 at a squash court, Slovenia, March 2020: case report.
    Epidemiol Infect. 2020;148:e120.
    PubMed     Abstract available

  200. YANG L, Dai J, Zhao J, Wang Y, et al
    Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China.
    Epidemiol Infect. 2020;148:e117.
    PubMed     Abstract available

  201. FORTALEZA CMCB, Guimaraes RB, de Almeida GB, Pronunciate M, et al
    Taking the inner route: spatial and demographic factors affecting vulnerability to COVID-19 among 604 cities from inner Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e118.
    PubMed     Abstract available

  202. ELLIOT AJ, Harcourt SE, Hughes HE, Loveridge P, et al
    The COVID-19 pandemic: a new challenge for syndromic surveillance.
    Epidemiol Infect. 2020;148:e122.
    PubMed     Abstract available

  203. ZHAO H, Lu X, Deng Y, Tang Y, et al
    COVID-19: asymptomatic carrier transmission is an underestimated problem.
    Epidemiol Infect. 2020;148:e116.
    PubMed     Abstract available

  204. THAI PQ, Toan DTT, Son DT, Van HTH, et al
    Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
    Epidemiol Infect. 2020;148:e114.
    PubMed     Abstract available

  205. HAIDER N, Yavlinsky A, Kock R
    Response to 'Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa' (Epidemiology and Infection - HYG-LE-10513-May-20).
    Epidemiol Infect. 2020;148:e112.

  206. KHOSRAVI A, Chaman R, Rohani-Rasaf M, Zare F, et al
    The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran.
    Epidemiol Infect. 2020;148:e115.
    PubMed     Abstract available

  207. MIYACHI T, Tanimoto T, Kami M
    Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa.
    Epidemiol Infect. 2020;148:e113.
    PubMed     Abstract available

  208. MASSAD E, Amaku M, Wilder-Smith A, Costa Dos Santos PC, et al
    Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre. The case of COVID-19.
    Epidemiol Infect. 2020;148:e109.
    PubMed     Abstract available

  209. WALKER MD, Sulyok M
    Online behavioural patterns for Coronavirus disease 2019 (COVID-19) in the United Kingdom.
    Epidemiol Infect. 2020;148:e110.
    PubMed     Abstract available

  210. LIU BM, Yang QQ, Zhao LY, Xie W, et al
    Epidemiological characteristics of COVID-19 patients in convalescence period.
    Epidemiol Infect. 2020;148:e108.
    PubMed     Abstract available

    May 2020
  211. ZHANG J, Wu J, Sun X, Xue H, et al
    Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.
    Epidemiol Infect. 2020;148:e106.
    PubMed     Abstract available

  212. LIU CY, Yang YZ, Zhang XM, Xu X, et al
    The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a cross-sectional survey.
    Epidemiol Infect. 2020;148:e98.
    PubMed     Abstract available

  213. SUN D, Yang D, Li Y, Zhou J, et al
    Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in China.
    Epidemiol Infect. 2020;148:e96.
    PubMed     Abstract available

  214. ZHOU ZM, Zhou HZ, Lin XD, Su ZC, et al
    Outbreak of COVID-19 in a family, Wenzhou, China.
    Epidemiol Infect. 2020;148:e103.
    PubMed     Abstract available

  215. CHEN H, Chen Y, Lian Z, Wen L, et al
    Correlation between the migration scale index and the number of new confirmed coronavirus disease 2019 cases in China.
    Epidemiol Infect. 2020;148:e99.
    PubMed     Abstract available

    Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian data.
    Epidemiol Infect. 2020;148:e97.
    PubMed     Abstract available

  217. MANGIAROTTI S, Peyre M, Zhang Y, Huc M, et al
    Chaos theory applied to the outbreak of COVID-19: an ancillary approach to decision making in pandemic context.
    Epidemiol Infect. 2020;148:e95.
    PubMed     Abstract available

  218. JI M, Yuan L, Shen W, Lv J, et al
    Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.
    Epidemiol Infect. 2020;148:e94.
    PubMed     Abstract available

    April 2020
    What might the future bring? COVID-19 planning considerations for faculty and universities.
    Epidemiol Infect. 2020;148:e92.
    PubMed     Abstract available

  220. YU HP, Ma LL, Hung YY, Wang XB, et al
    Application of 'mobile hospital' against 2019-nCoV in China.
    Epidemiol Infect. 2020;148:e111.

    The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020.
    Epidemiol Infect. 2020;148:e82.
    PubMed     Abstract available

    March 2020
  222. CRAIG AT, Heywood AE, Hall J
    Risk of COVID-19 importation to the Pacific islands through global air travel.
    Epidemiol Infect. 2020;148:e71.
    PubMed     Abstract available

  223. ER JC, Lium B, Framstad T
    Antibodies of Influenza A(H1N1)pdm09 virus in pigs' sera cross-react with other influenza A virus subtypes. A retrospective epidemiological interpretation of Norway's serosurveillance data from 2009-2017.
    Epidemiol Infect. 2020 Mar 13:1-30. doi: 10.1017/S0950268820000643.

    February 2020
  224. HAIDER N, Yavlinsky A, Simons D, Osman AY, et al
    Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.
    Epidemiol Infect. 2020;148:e41.
    PubMed     Abstract available

  225. TASIAME W, Johnson S, Burimuah V, Akyereko E, et al
    Outbreak of Highly Pathogenic Avian Influenza in Ghana, 2015: degree of losses and outcomes of time-course outbreak management.
    Epidemiol Infect. 2020 Feb 17:1-19. doi: 10.1017/S095026882000045.

  226. MAO H, Sun Y, Chen Y, Lou X, et al
    Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017-2018 influenza season in Zhejiang Province, China.
    Epidemiol Infect. 2020 Feb 14:1-13. doi: 10.1017/S0950268820000412.

  227. CHEN Y, Leng K, Lu Y, Wen L, et al
    Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010-2018.
    Epidemiol Infect. 2020;148:e29.
    PubMed     Abstract available

  228. TIN TIN HTAR M, Yerramalla MS, Moisi JC, Swerdlow DL, et al
    The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e48.
    PubMed     Abstract available

  229. MCCLOSKEY B, Heymann DL
    SARS to novel coronavirus - old lessons and new lessons.
    Epidemiol Infect. 2020;148:e22.
    PubMed     Abstract available

    December 2019
  230. LIU W, Dai Q, Bao J, Shen W, et al
    Influenza activity prediction using meteorological factors in a warm temperate to subtropical transitional zone, Eastern China.
    Epidemiol Infect. 2019;147:e325.
    PubMed     Abstract available

  231. MARTIN LJ, Dong H, Liu Q, Talbot J, et al
    Predicting influenza-like illness-related emergency department visits by modelling spatio-temporal syndromic surveillance data.
    Epidemiol Infect. 2019;147:e312.
    PubMed     Abstract available

    November 2019
  232. MINNEY-SMITH CA, Selvey LA, Levy A, Smith DW, et al
    Post-pandemic influenza A/H1N1pdm09 is associated with more severe outcomes than A/H3N2 and other respiratory viruses in adult hospitalisations.
    Epidemiol Infect. 2019;147:e310.
    PubMed     Abstract available

  233. LIPSITCH M, Goldstein E, Ray GT, Fireman B, et al
    Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results.
    Epidemiol Infect. 2019;147:e306.
    PubMed     Abstract available

  234. YANG J, Li H, Jia L, Lan X, et al
    High expression levels of influenza virus receptors in airway of the HBV-transgenic mice.
    Epidemiol Infect. 2019;147:e297.
    PubMed     Abstract available

    October 2019
  235. SCOTT EM, Magaret A, Kuypers J, Tielsch JM, et al
    Risk factors and patterns of household clusters of respiratory viruses in rural Nepal.
    Epidemiol Infect. 2019;147:e288.
    PubMed     Abstract available

    September 2019
  236. CHEN LL, Wu WL, Chan WM, Fong CHY, et al
    Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Epidemiol Infect. 2019;147:e279.
    PubMed     Abstract available

  237. KALISH T, Miron D, Azrad M, Rechnitzer H, et al
    Characteristics of hospitalised patients with influenza in 2015-2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1.
    Epidemiol Infect. 2019;147:e278.
    PubMed     Abstract available

  238. SIMPSON RB, Alarcon Falconi TM, Venkat A, Chui KHH, et al
    Incorporating calendar effects to predict influenza seasonality in Milwaukee, Wisconsin.
    Epidemiol Infect. 2019;147:e268.
    PubMed     Abstract available

  239. SUN X, Douiri A, Gulliford M
    Pneumonia incidence trends in UK primary care from 2002 to 2017: population-based cohort study.
    Epidemiol Infect. 2019;147:e263.
    PubMed     Abstract available

    January 2019
  240. VILCHES TN, Jaberi-Douraki M, Moghadas SM
    Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour.
    Epidemiol Infect. 2019;147:e75.
    PubMed     Abstract available

  241. KORSUN NS, Angelova SG, Trifonova IT, Georgieva IL, et al
    Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season.
    Epidemiol Infect. 2019;147:e76.
    PubMed     Abstract available

  242. PAN M, Yang HP, Jian J, Kuang Y, et al
    Association of meteorological factors with seasonal activity of influenza A subtypes and B lineages in subtropical western China.
    Epidemiol Infect. 2019;147:e72.
    PubMed     Abstract available

  243. SSEMATIMBA A, Malladi S, Hagenaars TJ, Bonney PJ, et al
    Estimating within-flock transmission rate parameter for H5N2 highly pathogenic avian influenza virus in Minnesota turkey flocks during the 2015 epizootic.
    Epidemiol Infect. 2019;147:e179.
    PubMed     Abstract available

  244. MALOSH RE, Noppert GA, Zelner J, Martin ET, et al
    Social patterning of acute respiratory illnesses in the Household Influenza Vaccine Evaluation (HIVE) Study 2014-2015.
    Epidemiol Infect. 2019;147:e185.
    PubMed     Abstract available

  245. FERNANDES-MATANO L, Monroy-Munoz IE, Bermudez de Leon M, Leal-Herrera YA, et al
    Analysis of influenza data generated by four epidemiological surveillance laboratories in Mexico, 2010-2016.
    Epidemiol Infect. 2019;147:e183.
    PubMed     Abstract available

  246. HARCOURT SE, Morbey RA, Smith GE, Loveridge P, et al
    Developing influenza and respiratory syncytial virus activity thresholds for syndromic surveillance in England.
    Epidemiol Infect. 2019;147:e163.
    PubMed     Abstract available

  247. MCHUGH L, Andrews RM, Leckning B, Snelling T, et al
    Baseline incidence of adverse birth outcomes and infant influenza and pertussis hospitalisations prior to the introduction of influenza and pertussis vaccination in pregnancy: a data linkage study of 78 382 mother-infant pairs, Northern Territory, Aus
    Epidemiol Infect. 2019;147:e233.
    PubMed     Abstract available

  248. BODDINGTON NL, Warburton F, Zhao H, Andrews N, et al
    Influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children in England in the 2015-2016 influenza season - a test-negative case-control study.
    Epidemiol Infect. 2019;147:e201.
    PubMed     Abstract available

  249. KOMADINA N, Sullivan SG, Kedzierska K, Quinones-Parra SM, et al
    Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.
    Epidemiol Infect. 2019;147:e213.
    PubMed     Abstract available

  250. WONG JY, Goldstein E, Fang VJ, Cowling BJ, et al
    Real-time estimation of the influenza-associated excess mortality in Hong Kong.
    Epidemiol Infect. 2019;147:e217.
    PubMed     Abstract available

  251. PRICE OH, Sullivan SG, Sutterby C, Druce J, et al
    Using routine testing data to understand circulation patterns of influenza A, respiratory syncytial virus and other respiratory viruses in Victoria, Australia.
    Epidemiol Infect. 2019;147:e221.
    PubMed     Abstract available

  252. PRASAD N, Newbern EC, Trenholme AA, Wood T, et al
    Respiratory syncytial virus hospitalisations among young children: a data linkage study.
    Epidemiol Infect. 2019;147:e246.
    PubMed     Abstract available

    December 2018
  253. RASMUSSEN IS, Mortensen LH, Krause TG, Nybo Andersen AM, et al
    The association between seasonal influenza-like illness cases and foetal death: a time series analysis.
    Epidemiol Infect. 2018 Dec 3:1-7. doi: 10.1017/S0950268818003254.
    PubMed     Abstract available

    November 2018
  254. CHEN T, Xiao M, Yang J, Chen YK, et al
    Association between rs12252 and influenza susceptibility and severity: an updated meta-analysis.
    Epidemiol Infect. 2018 Nov 13:1-9. doi: 10.1017/S0950268818002832.
    PubMed     Abstract available

    October 2018
  255. TEIRLINCK AC, de Gier B, Meijer A, Donker G, et al
    The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis.
    Epidemiol Infect. 2018 Oct 23:1-6. doi: 10.1017/S095026881800273.
    PubMed     Abstract available

    September 2018
  256. NIANG MN, Barry MA, Talla C, Mbengue A, et al
    Estimation of the burden of flu-association influenza-like illness visits on total clinic visits through the sentinel influenza monitoring system in Senegal during the 2013-2015 influenza seasons.
    Epidemiol Infect. 2018 Sep 10:1-7. doi: 10.1017/S0950268818002418.
    PubMed     Abstract available

    August 2018
  257. PEBODY RG, Boddington NL, Green HK, Bolotin S, et al
    Assessing the severity of influenza: a role for longitudinal telephone surveys?
    Epidemiol Infect. 2018 Aug 15:1-7. doi: 10.1017/S0950268818002261.
    PubMed     Abstract available

  258. MORBEY RA, Elliot AJ, Harcourt S, Smith S, et al
    Estimating the burden on general practitioner services in England from increases in respiratory disease associated with seasonal respiratory pathogen activity.
    Epidemiol Infect. 2018;146:1389-1396.
    PubMed     Abstract available

  259. ZHANG X, Chen Z, Gu W, Ji W, et al
    Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia.
    Epidemiol Infect. 2018;146:1384-1388.
    PubMed     Abstract available

    July 2018
  260. HALPIN AL, Gu W, Wise ME, Sejvar JJ, et al
    Post-Campylobacter Guillain Barre Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign.
    Epidemiol Infect. 2018 Jul 10:1-6. doi: 10.1017/S0950268818001802.
    PubMed     Abstract available

  261. DEMBEK ZF, Chekol T, Wu A
    Best practice assessment of disease modelling for infectious disease outbreaks.
    Epidemiol Infect. 2018;146:1207-1215.
    PubMed     Abstract available

    June 2018
  262. LEI H, Tang JW, Li Y
    Transmission routes of influenza A(H1N1)pdm09: analyses of inflight outbreaks.
    Epidemiol Infect. 2018 Jun 29:1-9. doi: 10.1017/S0950268818001772.
    PubMed     Abstract available

  263. SANTAK M, Lang Balija M, Mlinaric Galinovic G, Ljubin Sternak S, et al
    Genotype replacement of the human parainfluenza virus type 2 in Croatia between 2011 and 2017 - the role of neutralising antibodies.
    Epidemiol Infect. 2018 Jun 18:1-12. doi: 10.1017/S0950268818001693.
    PubMed     Abstract available

  264. RUSSELL K, Herrick K, Venkat H, Brady S, et al
    Utility of state-level influenza disease burden and severity estimates to investigate an apparent increase in reported severe cases of influenza A(H1N1) pdm09 - Arizona, 2015-2016.
    Epidemiol Infect. 2018 Jun 14:1-7. doi: 10.1017/S0950268818001516.
    PubMed     Abstract available

  265. SEGALOFF HE, Petrie JG, Malosh RE, Cheng CK, et al
    Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016.
    Epidemiol Infect. 2018 Jun 8:1-9. doi: 10.1017/S0950268818001486.
    PubMed     Abstract available

    May 2018
  266. GUYTHER J, Lichenstein R, Gao Y, Zhou JA, et al
    Association of influenza outbreaks with advanced pediatric medical support.
    Epidemiol Infect. 2018 May 30:1-6. doi: 10.1017/S0950268818001383.
    PubMed     Abstract available

  267. PARVIN R, Begum JA, Nooruzzaman M, Chowdhury EH, et al
    Review analysis and impact of co-circulating H5N1 and H9N2 avian influenza viruses in Bangladesh.
    Epidemiol Infect. 2018 May 21:1-8. doi: 10.1017/S0950268818001292.
    PubMed     Abstract available

  268. PEBODY RG, Green HK, Warburton F, Sinnathamby M, et al
    Significant spike in excess mortality in England in winter 2014/15 - influenza the likely culprit.
    Epidemiol Infect. 2018 May 10:1-8. doi: 10.1017/S0950268818001152.
    PubMed     Abstract available

  269. XIAO S, Tang JW, Hui DS, Lei H, et al
    Probable transmission routes of the influenza virus in a nosocomial outbreak.
    Epidemiol Infect. 2018 May 6:1-9. doi: 10.1017/S0950268818001012.
    PubMed     Abstract available

    April 2018
  270. LEE JJ, Bankhead C, Smith M, Kousoulis AA, et al
    Risk factors for influenza-related complications in children during the 2009/10 pandemic: a UK primary care cohort study using linked routinely collected data.
    Epidemiol Infect. 2018 Apr 15:1-7. doi: 10.1017/S0950268818000353.
    PubMed     Abstract available

  271. DOMINGUEZ A, Romero-Tamarit A, Soldevila N, Godoy P, et al
    Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons.
    Epidemiol Infect. 2018 Apr 2:1-10. doi: 10.1017/S0950268818000663.
    PubMed     Abstract available

  272. ZHANG J, Nawata K
    Multi-step prediction for influenza outbreak by an adjusted long short-term memory.
    Epidemiol Infect. 2018 Apr 2:1-8. doi: 10.1017/S0950268818000705.
    PubMed     Abstract available

  273. HUGHES JM, Penney C, Boyd S, Daley P, et al
    Risk of bias and limits of reporting in diagnostic accuracy studies for commercial point-of-care tests for respiratory pathogens.
    Epidemiol Infect. 2018;146:747-756.
    PubMed     Abstract available

  274. MORLEY C, Grimwood K, Maloney S, Ware RS, et al
    Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia.
    Epidemiol Infect. 2018;146:757-762.
    PubMed     Abstract available

    February 2018
  275. WU DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, et al
    Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.
    Epidemiol Infect. 2018 Feb 15:1-12. doi: 10.1017/S0950268818000158.
    PubMed     Abstract available

    January 2018
  276. ARNOLD ME, Slomka MJ, Breed AC, Hjulsager CK, et al
    Evaluation of ELISA and haemagglutination inhibition as screening tests in serosurveillance for H5/H7 avian influenza in commercial chicken flocks.
    Epidemiol Infect. 2018 Jan 12:1-8. doi: 10.1017/S0950268817002898.
    PubMed     Abstract available

    December 2017
  277. MOHL A, Grafe L, Helmeke C, Ziehm D, et al
    Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016.
    Epidemiol Infect. 2017 Dec 6:1-11. doi: 10.1017/S0950268817002709.
    PubMed     Abstract available

  278. SOUTY C, Jreich R, LE Strat Y, Pelat C, et al
    Performances of statistical methods for the detection of seasonal influenza epidemics using a consensus-based gold standard.
    Epidemiol Infect. 2017 Dec 6:1-9. doi: 10.1017/S095026881700276.
    PubMed     Abstract available

    November 2017
  279. NAGY A, Mettenleiter TC, Abdelwhab EM
    A brief summary of the epidemiology and genetic relatedness of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa.
    Epidemiol Infect. 2017 Nov 23:1-14. doi: 10.1017/S0950268817002576.
    PubMed     Abstract available

  280. ADEOLA OA, Olugasa BO, Emikpe BO
    Molecular detection of influenza A(H1N1)pdm09 viruses with M genes from human pandemic strains among Nigerian pigs, 2013-2015: implications and associated risk factors.
    Epidemiol Infect. 2017 Nov 23:1-16. doi: 10.1017/S0950268817002503.
    PubMed     Abstract available

  281. WU S, VAN Asten L, Wang L, McDonald SA, et al
    Estimated incidence and number of outpatient visits for seasonal influenza in 2015-2016 in Beijing, China.
    Epidemiol Infect. 2017 Nov 9:1-11. doi: 10.1017/S0950268817002369.
    PubMed     Abstract available

  282. PARK E, Park PH, Huh JW, Yun HJ, et al
    Molecular and clinical characterization of human respiratory syncytial virus in South Korea between 2009 and 2014.
    Epidemiol Infect. 2017;145:3226-3242.
    PubMed     Abstract available

    October 2017
  283. ZIVICH PN, Tatham L, Lung K, Tien J, et al
    Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).
    Epidemiol Infect. 2017 Oct 16:1-10. doi: 10.1017/S0950268817002163.
    PubMed     Abstract available

    September 2017
  284. REGAN AK, Moore HC, Sullivan SG, DE Klerk N, et al
    Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes.
    Epidemiol Infect. 2017 Sep 11:1-10. doi: 10.1017/S0950268817001972.
    PubMed     Abstract available

    August 2017
  285. TOWERS S
    Sunspot activity and influenza pandemics: a statistical assessment of the purported association.
    Epidemiol Infect. 2017 Aug 29:1-16. doi: 10.1017/S095026881700173.
    PubMed     Abstract available

  286. BARDE PV, Sahu M, Shukla MK, Bharti PK, et al
    The high frequency of non-aspartic acid residues at HA222 in influenza A(H1N1) 2009 pandemic viruses is associated with mortality during the upsurge of 2015: a molecular and epidemiological study from central India.
    Epidemiol Infect. 2017 Aug 3:1-10. doi: 10.1017/S0950268817001595.
    PubMed     Abstract available

    July 2017
  287. MGBERE O, Ngo K, Khuwaja S, Mouzoon M, et al
    Pandemic-related health behavior: repeat episodes of influenza-like illness related to the 2009 H1N1 influenza pandemic.
    Epidemiol Infect. 2017 Jul 20:1-7. doi: 10.1017/S0950268817001467.
    PubMed     Abstract available

  288. MORBEY RA, Harcourt S, Pebody R, Zambon M, et al
    The burden of seasonal respiratory infections on a national telehealth service in England.
    Epidemiol Infect. 2017;145:1922-1932.
    PubMed     Abstract available

    June 2017
  289. KING JC, Schweinle JE, Hatchett RJ, Gao Y, et al
    Surges of advanced medical support associated with influenza outbreaks.
    Epidemiol Infect. 2017 Jun 9:1-8. doi: 10.1017/S095026881700111.
    PubMed     Abstract available

    May 2017
  290. SPRECO A, Eriksson O, Dahlstrom O, Timpka T, et al
    Influenza detection and prediction algorithms: comparative accuracy trial in Ostergotland county, Sweden, 2008-2012.
    Epidemiol Infect. 2017 May 17:1-10. doi: 10.1017/S0950268817001005.
    PubMed     Abstract available

    April 2017
  291. SANTOS AJ, Kislaya I, Machado A, Nunes B, et al
    Beliefs and attitudes towards the influenza vaccine in high-risk individuals.
    Epidemiol Infect. 2017 Apr 24:1-11. doi: 10.1017/S0950268817000814.
    PubMed     Abstract available

  292. GURAV YK, Chadha MS, Tandale BV, Potdar VA, et al
    Influenza A(H1N1)pdm09 outbreak detected in inter-seasonal months during the surveillance of influenza-like illness in Pune, India, 2012-2015.
    Epidemiol Infect. 2017 Apr 3:1-12. doi: 10.1017/S0950268817000553.
    PubMed     Abstract available

  293. INAIDA S, Tsuda T, Matsuno S
    Correlation between infectious disease and soil radiation in Japan: an exploratory study using national sentinel surveillance data.
    Epidemiol Infect. 2017;145:1183-1192.
    PubMed     Abstract available

    March 2017
  294. PINTO LA, DE Azeredo Leitao LA, Mocellin M, Acosta P, et al
    IL-8/IL-17 gene variations and the susceptibility to severe viral bronchiolitis.
    Epidemiol Infect. 2017;145:642-646.
    PubMed     Abstract available

    February 2017
  295. BODDINGTON NL, Verlander NQ, Pebody RG
    Developing a system to estimate the severity of influenza infection in England: findings from a hospital-based surveillance system between 2010/2011 and 2014/2015.
    Epidemiol Infect. 2017 Feb 7:1-10. doi: 10.1017/S095026881700005.
    PubMed     Abstract available

  296. LI-KIM-MOY J, Yin JK, Blyth CC, Kesson A, et al
    Influenza hospitalizations in Australian children.
    Epidemiol Infect. 2017 Feb 6:1-10. doi: 10.1017/S0950268816003381.
    PubMed     Abstract available

    January 2017
  297. PINI A, Merk H, Carnahan A, Galanis I, et al
    High added value of a population-based participatory surveillance system for community acute gastrointestinal, respiratory and influenza-like illnesses in Sweden, 2013-2014 using the web.
    Epidemiol Infect. 2017 Jan 31:1-10. doi: 10.1017/S0950268816003290.
    PubMed     Abstract available

  298. ZHAO H, Harris RJ, Ellis J, Donati M, et al
    Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change?
    Epidemiol Infect. 2017 Jan 18:1-11. doi: 10.1017/S095026881600323.
    PubMed     Abstract available

  299. JACOBY P, Glass K, Moore HC
    Characterizing the risk of respiratory syncytial virus in infants with older siblings: a population-based birth cohort study.
    Epidemiol Infect. 2017;145:266-271.
    PubMed     Abstract available

  300. WIN MK, Chow A, Ho HJ, Tay SY, et al
    Risk assessment and laboratory investigation of respiratory illness in travellers returning to Singapore 2012-2015: experience from the MERS-CoV Surveillance Programme.
    Epidemiol Infect. 2017;145:285-288.
    PubMed     Abstract available

  301. SHOBUGAWA Y, Takeuchi T, Hibino A, Hassan MR, et al
    Occurrence of human respiratory syncytial virus in summer in Japan.
    Epidemiol Infect. 2017;145:272-284.
    PubMed     Abstract available

    December 2016
  302. ANG LW, Cutter J, James L, Goh KT, et al
    Factors associated with influenza vaccine uptake in older adults living in the community in Singapore.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

  303. BANGERT M, Gil H, Oliva J, Delgado C, et al
    Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM).
    Epidemiol Infect. 2016.
    PubMed     Abstract available

  304. WARDELL R, Prem K, Cowling BJ, Cook AR, et al
    The role of symptomatic presentation in influenza A transmission risk.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

    November 2016
  305. MARTIN LJ
    A look back: investigating Google Flu Trends during the influenza A(H1N1)pdm09 pandemic in Canada, 2009-2010.
    Epidemiol Infect. 2016.

  306. CHEN TM, Chen QP, Liu RC, Szot A, et al
    The transmissibility estimation of influenza with early stage data of small-scale outbreaks in Changsha, China, 2005-2013.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

    October 2016
  307. CHUGHTAI AA, Wang Q, Dung TC, Macintyre CR, et al
    The presence of fever in adults with influenza and other viral respiratory infections.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

    September 2016
  308. DELABRE RM, Salez N, Lapidus N, Lemaitre M, et al
    Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

  309. HE F, Lin JF, Wang XY, Li FD, et al
    Quantitative risk analysis of the novel H7N9 virus in environments associated with H9 avian influenza virus, Zhejiang province, China.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

  310. MOSS R, Zarebski A, Dawson P, McCAW JM, et al
    Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.
    Epidemiol Infect. 2016.
    PubMed     Abstract available

  311. GREEN HK, Brousseau N, Andrews N, Selby L, et al
    Illness absenteeism rates in primary and secondary schools in 2013-2014 in England: was there any impact of vaccinating children of primary-school age against influenza?
    Epidemiol Infect. 2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.